Date(s) And Time(s):
Jan 9 2011 8:00AM - Jan 12 2011 5:00PM
Renaissance Washington, DC Hotel
999 9th Street NW
Washington, DC 20001-9000
Several preconference workshops are being developed and will be offered on January 9, 2011. Monitor www.diahome.org for information as it becomes available.
Clinical trial safety and postmarketing pharmacovigilance is more critical than ever in the development and evaluation of the safe use of marketed medical products. This comprehensive three-day program will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, how to optimally utilize epidemiological, clinical pharmacological and other techniques, risk management strategies, and how to create an effective organizational “system.” This program will focus primarily on drug products and biologics, but medical devices will have a limited role in the discussions.
Contact Rachel Minnick, Program Developer, Phone +1.215.442.6131
Fax +1.215.442.6199, email Rachel.Minnick@diahome.org
TABLETOP EXHIBIT INFORMATION
Attendees may visit the tabletop exhibits during the event and receptions.
For further information, contact Jeff Korn, Exhibits Associate,
Phone +1.215.442.6184 / Fax +1.215.442.6199, email Jeff.Korn@diahome.org